Brief: Peptonic Q3 Operating Loss Widens To SEK 7.3 Million
Nov 10 (Reuters) - Peptonic Medical AB PMED.TE :
* INTERIM REPORT PERIOD FROM JANUARY 2020 TO SEPTEMBER 2020
* Q3 NET SALES OF PRODUCTS KSEK 9 260 (1 533)
* Q3 OPERATING LOSS SEK 7.3 MILLION VERSUS LOSS SEK 4.1
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr3VMfWS
Further company coverage: PMED.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Peptonic Medical AB
See all newsSweden's Peptonic Medical Q2 sales drop, gross margin narrows
Brief: Peptonic Medical Q2 Sales SEK 2.36 Million
Sweden's Peptonic Medical Q1 operating loss narrows on restructuring
Brief: Peptonic Medical Q1 Sales SEK 3.138 Million
Sweden's Peptonic Medical Q4 sales fall, margin improves on restructuring efforts